Share Price and Basic Stock Data
Last Updated: November 14, 2025, 10:59 pm
| PEG Ratio | -3.25 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Ambica Agarbathies Aroma & Industries Ltd, operating in the personal care sector, reported a market capitalization of ₹43.1 Cr and a stock price of ₹25.1. The company has shown fluctuations in revenue, with sales for the trailing twelve months (TTM) recorded at ₹131 Cr. Historically, sales figures have varied, with ₹117 Cr reported in March 2023, down from ₹116 Cr in March 2022. The quarterly sales have demonstrated volatility, with the highest quarterly sales reaching ₹35.16 Cr in March 2023 before declining to ₹21.25 Cr in June 2023. However, a rebound was observed in subsequent quarters, with ₹28.93 Cr in December 2023 and ₹23.51 Cr in September 2024. This revenue pattern indicates potential challenges in maintaining consistent sales performance, reflective of broader market trends in the personal care industry.
Profitability and Efficiency Metrics
Profitability metrics for Ambica Agarbathies show a mixed performance. The net profit for the TTM stood at ₹1 Cr, with a net profit margin of 0.39% as of March 2025, indicating subdued profitability levels compared to typical industry standards. The operating profit margin (OPM) was recorded at 10.25%, with the highest recorded OPM of 15.30% in June 2024, suggesting moments of operational efficiency. However, the company faced challenges, with negative net profits in several quarters, including a loss of ₹1.94 Cr in March 2025. The interest coverage ratio (ICR) was 1.43x, indicating the firm’s ability to meet interest obligations, but still below a satisfactory threshold. Overall, while the company has shown potential in operational profitability, it faces significant hurdles in achieving sustainable net profits.
Balance Sheet Strength and Financial Ratios
Ambica Agarbathies’ balance sheet reflects a total debt of ₹82 Cr against reserves of ₹92 Cr, resulting in a manageable debt-to-equity ratio of 0.68x. The current ratio stood at 2.69x, indicating solid short-term liquidity, while the quick ratio was at 2.52x, suggesting that the company can cover its immediate liabilities without relying heavily on inventory. However, the return on equity (ROE) of 0.45% and return on capital employed (ROCE) of 7.49% are relatively low, reflecting underutilization of equity and capital in generating profits. The book value per share was ₹63.62, which, when compared to the market price, highlights a P/BV ratio of 0.42x, indicating that the stock may be undervalued relative to its net asset value. The financial ratios suggest a stable balance sheet but raise concerns regarding overall capital efficiency.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Ambica Agarbathies indicates a stable distribution, with promoters holding 43.41% of the shares, while the public holds 56.58%. This ownership structure may instill confidence among retail investors, although the lack of Foreign Institutional Investors (FIIs) at 0% suggests limited institutional interest. Over recent quarters, promoter holdings have gradually declined from 48.35% in September 2022, potentially raising concerns about insider confidence. The number of shareholders has also decreased from 9,688 in September 2022 to 8,649 by June 2025, indicating a possible exit of investors. This diminishing shareholder base could affect the stock’s liquidity and overall market perception, highlighting the need for the company to engage effectively with its investor community.
Outlook, Risks, and Final Insight
Ambica Agarbathies faces both opportunities and risks moving forward. On the one hand, the company’s ability to achieve an OPM of 10.25% and a current ratio of 2.69x indicates operational resilience and financial stability. However, risks persist, including fluctuating sales, negative net profits in multiple quarters, and a declining shareholder base. The personal care industry is competitive, and the company’s limited institutional backing may hinder growth prospects. To enhance investor confidence, Ambica must focus on improving profitability, maintaining operational efficiencies, and potentially restructuring its sales strategy. If the company can stabilize its revenue and enhance profitability metrics, it may attract more institutional interest and investor confidence. Conversely, failure to address these challenges could further erode market position and shareholder value.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Ambica Agarbathies Aroma & Industries Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Honasa Consumer Ltd | 9,291 Cr. | 286 | 334/190 | 74.7 | 38.8 | 0.00 % | 7.44 % | 5.51 % | 10.0 |
| Ambica Agarbathies Aroma & Industries Ltd | 44.7 Cr. | 25.8 | 37.0/23.3 | 87.7 | 65.2 | 0.00 % | 7.49 % | 0.45 % | 10.0 |
| Ador Multi Products Ltd | 106 Cr. | 111 | 119/23.4 | 19.4 | 0.00 % | 11.4 % | 3.09 % | 10.0 | |
| Kaya Ltd | 647 Cr. | 423 | 488/204 | 60.9 | 0.00 % | 2.50 % | % | 10.0 | |
| Jyothy Labs Ltd | 11,441 Cr. | 311 | 433/268 | 31.3 | 55.8 | 1.13 % | 24.6 % | 19.0 % | 1.00 |
| Industry Average | 66,837.13 Cr | 1,948.94 | 56.72 | 111.56 | 0.74% | 29.21% | 23.91% | 4.94 |
All Competitor Stocks of Ambica Agarbathies Aroma & Industries Ltd
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 20.93 | 29.20 | 31.95 | 35.16 | 21.25 | 24.31 | 28.93 | 23.35 | 23.01 | 33.51 | 36.05 | 31.05 | 30.14 |
| Expenses | 20.75 | 28.31 | 28.87 | 31.93 | 20.23 | 23.87 | 27.20 | 22.75 | 19.49 | 30.42 | 33.70 | 29.78 | 27.05 |
| Operating Profit | 0.18 | 0.89 | 3.08 | 3.23 | 1.02 | 0.44 | 1.73 | 0.60 | 3.52 | 3.09 | 2.35 | 1.27 | 3.09 |
| OPM % | 0.86% | 3.05% | 9.64% | 9.19% | 4.80% | 1.81% | 5.98% | 2.57% | 15.30% | 9.22% | 6.52% | 4.09% | 10.25% |
| Other Income | 0.00 | 2.76 | 0.72 | 1.88 | 0.01 | 0.49 | 0.03 | 4.82 | 1.05 | 1.42 | 1.51 | 1.33 | 1.74 |
| Interest | 1.83 | 1.74 | 1.76 | 2.51 | 2.06 | 2.09 | 2.07 | 3.49 | 2.65 | 2.84 | 2.93 | 2.44 | 2.72 |
| Depreciation | 0.82 | 0.82 | 0.82 | -0.60 | 0.46 | 0.46 | 0.46 | 0.31 | 0.42 | 0.42 | 0.42 | 0.73 | 0.59 |
| Profit before tax | -2.47 | 1.09 | 1.22 | 3.20 | -1.49 | -1.62 | -0.77 | 1.62 | 1.50 | 1.25 | 0.51 | -0.57 | 1.52 |
| Tax % | -18.22% | 0.00% | -36.89% | 44.69% | 8.72% | -8.02% | 0.00% | 86.42% | 25.33% | 25.60% | 25.49% | 240.35% | 25.00% |
| Net Profit | -2.02 | 1.10 | 1.67 | 1.78 | -1.62 | -1.49 | -0.77 | 0.22 | 1.12 | 0.93 | 0.38 | -1.94 | 1.14 |
| EPS in Rs | -1.18 | 0.64 | 0.97 | 1.04 | -0.94 | -0.87 | -0.45 | 0.13 | 0.65 | 0.54 | 0.22 | -1.13 | 0.66 |
Last Updated: August 19, 2025, 11:55 pm
Below is a detailed analysis of the quarterly data for Ambica Agarbathies Aroma & Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 30.14 Cr.. The value appears to be declining and may need further review. It has decreased from 31.05 Cr. (Mar 2025) to 30.14 Cr., marking a decrease of 0.91 Cr..
- For Expenses, as of Jun 2025, the value is 27.05 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 29.78 Cr. (Mar 2025) to 27.05 Cr., marking a decrease of 2.73 Cr..
- For Operating Profit, as of Jun 2025, the value is 3.09 Cr.. The value appears strong and on an upward trend. It has increased from 1.27 Cr. (Mar 2025) to 3.09 Cr., marking an increase of 1.82 Cr..
- For OPM %, as of Jun 2025, the value is 10.25%. The value appears strong and on an upward trend. It has increased from 4.09% (Mar 2025) to 10.25%, marking an increase of 6.16%.
- For Other Income, as of Jun 2025, the value is 1.74 Cr.. The value appears strong and on an upward trend. It has increased from 1.33 Cr. (Mar 2025) to 1.74 Cr., marking an increase of 0.41 Cr..
- For Interest, as of Jun 2025, the value is 2.72 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.44 Cr. (Mar 2025) to 2.72 Cr., marking an increase of 0.28 Cr..
- For Depreciation, as of Jun 2025, the value is 0.59 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.73 Cr. (Mar 2025) to 0.59 Cr., marking a decrease of 0.14 Cr..
- For Profit before tax, as of Jun 2025, the value is 1.52 Cr.. The value appears strong and on an upward trend. It has increased from -0.57 Cr. (Mar 2025) to 1.52 Cr., marking an increase of 2.09 Cr..
- For Tax %, as of Jun 2025, the value is 25.00%. The value appears to be improving (decreasing) as expected. It has decreased from 240.35% (Mar 2025) to 25.00%, marking a decrease of 215.35%.
- For Net Profit, as of Jun 2025, the value is 1.14 Cr.. The value appears strong and on an upward trend. It has increased from -1.94 Cr. (Mar 2025) to 1.14 Cr., marking an increase of 3.08 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.66. The value appears strong and on an upward trend. It has increased from -1.13 (Mar 2025) to 0.66, marking an increase of 1.79.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 3:59 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 94 | 98 | 104 | 119 | 125 | 138 | 168 | 143 | 116 | 117 | 98 | 124 | 132 |
| Expenses | 80 | 83 | 91 | 107 | 131 | 126 | 153 | 138 | 102 | 109 | 93 | 113 | 123 |
| Operating Profit | 14 | 14 | 13 | 12 | -5 | 12 | 14 | 6 | 14 | 8 | 5 | 10 | 9 |
| OPM % | 15% | 15% | 12% | 10% | -4% | 9% | 8% | 4% | 12% | 7% | 5% | 8% | 6% |
| Other Income | 1 | 1 | 1 | 2 | 2 | 3 | 0 | 4 | 1 | 5 | 5 | 5 | 7 |
| Interest | 10 | 9 | 9 | 9 | 9 | 8 | 8 | 7 | 12 | 9 | 11 | 11 | 10 |
| Depreciation | 4 | 4 | 3 | 3 | 5 | 4 | 3 | 3 | 3 | 2 | 2 | 2 | 2 |
| Profit before tax | 1 | 2 | 2 | 2 | -17 | 4 | 4 | -0 | 1 | 3 | -2 | 3 | 3 |
| Tax % | 20% | 26% | 33% | 32% | 3% | -188% | -17% | -648% | -300% | 17% | 62% | 81% | |
| Net Profit | 1 | 1 | 1 | 2 | -18 | 10 | 4 | 3 | 2 | 3 | -4 | 0 | 1 |
| EPS in Rs | 0.62 | 0.84 | 0.79 | 0.90 | -10.37 | 5.97 | 2.48 | 1.60 | 1.40 | 1.47 | -2.13 | 0.29 | 0.29 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 0.00% | 0.00% | 100.00% | -1000.00% | 155.56% | -60.00% | -25.00% | -33.33% | 50.00% | -233.33% | 100.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | 0.00% | 100.00% | -1100.00% | 1155.56% | -215.56% | 35.00% | -8.33% | 83.33% | -283.33% | 333.33% |
Ambica Agarbathies Aroma & Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | -6% |
| 3 Years: | 2% |
| TTM: | 31% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -21% |
| 3 Years: | -15% |
| TTM: | 155% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | % |
| 3 Years: | -7% |
| 1 Year: | -14% |
| Return on Equity | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 1% |
| 3 Years: | 0% |
| Last Year: | 1% |
Last Updated: September 5, 2025, 2:16 pm
No data available for the Balance Sheet data table.
Cash Flow - No data available for this post.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 28 | 32 | 26 | 26 | 36 | 38 | 46 | 21 | 91 | 60 | 35 | 42 |
| Inventory Days | 89 | 129 | 157 | 104 | 7 | 12 | 38 | 42 | 57 | 10 | 30 | 22 |
| Days Payable | 26 | 17 | 25 | 41 | 13 | 12 | 25 | 42 | 108 | 17 | 71 | 15 |
| Cash Conversion Cycle | 91 | 144 | 158 | 89 | 30 | 37 | 59 | 21 | 40 | 53 | -6 | 49 |
| Working Capital Days | 69 | 20 | -19 | -66 | 49 | 68 | 72 | 95 | 111 | 162 | 197 | 144 |
| ROCE % | 11% | 12% | 12% | 11% | -7% | 7% | 7% | 4% | 7% | 7% | 5% | 7% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 4.66 | -2.13 | 1.47 | 1.40 | 1.59 |
| Diluted EPS (Rs.) | 4.66 | -2.13 | 1.47 | 1.40 | 1.59 |
| Cash EPS (Rs.) | 1.45 | -1.15 | 2.54 | 3.30 | 3.43 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 63.62 | 58.96 | 61.09 | 59.63 | 58.24 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 63.62 | 58.96 | 61.09 | 59.63 | 58.24 |
| Revenue From Operations / Share (Rs.) | 71.96 | 56.96 | 68.25 | 67.72 | 83.48 |
| PBDIT / Share (Rs.) | 9.05 | 5.75 | 7.82 | 8.95 | 5.87 |
| PBIT / Share (Rs.) | 7.89 | 4.77 | 6.75 | 7.05 | 4.04 |
| PBT / Share (Rs.) | 1.57 | -1.31 | 1.78 | 0.34 | -0.29 |
| Net Profit / Share (Rs.) | 0.28 | -2.13 | 1.47 | 1.40 | 1.59 |
| PBDIT Margin (%) | 12.58 | 10.10 | 11.45 | 13.21 | 7.03 |
| PBIT Margin (%) | 10.96 | 8.37 | 9.88 | 10.41 | 4.83 |
| PBT Margin (%) | 2.17 | -2.30 | 2.60 | 0.51 | -0.34 |
| Net Profit Margin (%) | 0.39 | -3.74 | 2.15 | 2.06 | 1.90 |
| Return on Networth / Equity (%) | 0.44 | -3.61 | 2.40 | 2.34 | 2.73 |
| Return on Capital Employeed (%) | 6.99 | 4.29 | 6.14 | 6.55 | 3.62 |
| Return On Assets (%) | 0.21 | -1.73 | 1.24 | 1.09 | 1.29 |
| Long Term Debt / Equity (X) | 0.54 | 0.66 | 0.59 | 0.60 | 0.69 |
| Total Debt / Equity (X) | 0.68 | 0.66 | 0.59 | 0.62 | 0.69 |
| Asset Turnover Ratio (%) | 0.56 | 0.47 | 0.55 | 0.54 | 0.68 |
| Current Ratio (X) | 2.69 | 3.66 | 4.51 | 2.08 | 2.96 |
| Quick Ratio (X) | 2.52 | 3.39 | 4.34 | 1.70 | 2.29 |
| Inventory Turnover Ratio (X) | 4.76 | 4.36 | 4.33 | 0.75 | 0.83 |
| Interest Coverage Ratio (X) | 1.43 | 0.94 | 1.57 | 1.34 | 1.36 |
| Interest Coverage Ratio (Post Tax) (X) | 1.04 | 0.64 | 1.30 | 1.21 | 1.37 |
| Enterprise Value (Cr.) | 120.12 | 111.28 | 96.69 | 107.30 | 73.46 |
| EV / Net Operating Revenue (X) | 0.97 | 1.14 | 0.82 | 0.92 | 0.51 |
| EV / EBITDA (X) | 7.72 | 11.26 | 7.20 | 6.98 | 7.28 |
| MarketCap / Net Operating Revenue (X) | 0.37 | 0.46 | 0.29 | 0.38 | 0.04 |
| Price / BV (X) | 0.42 | 0.44 | 0.33 | 0.44 | 0.06 |
| Price / Net Operating Revenue (X) | 0.37 | 0.46 | 0.29 | 0.38 | 0.04 |
| EarningsYield | 0.01 | -0.08 | 0.07 | 0.05 | 0.39 |
After reviewing the key financial ratios for Ambica Agarbathies Aroma & Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 4.66. This value is below the healthy minimum of 5. It has increased from -2.13 (Mar 24) to 4.66, marking an increase of 6.79.
- For Diluted EPS (Rs.), as of Mar 25, the value is 4.66. This value is below the healthy minimum of 5. It has increased from -2.13 (Mar 24) to 4.66, marking an increase of 6.79.
- For Cash EPS (Rs.), as of Mar 25, the value is 1.45. This value is below the healthy minimum of 3. It has increased from -1.15 (Mar 24) to 1.45, marking an increase of 2.60.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 63.62. It has increased from 58.96 (Mar 24) to 63.62, marking an increase of 4.66.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 63.62. It has increased from 58.96 (Mar 24) to 63.62, marking an increase of 4.66.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 71.96. It has increased from 56.96 (Mar 24) to 71.96, marking an increase of 15.00.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 9.05. This value is within the healthy range. It has increased from 5.75 (Mar 24) to 9.05, marking an increase of 3.30.
- For PBIT / Share (Rs.), as of Mar 25, the value is 7.89. This value is within the healthy range. It has increased from 4.77 (Mar 24) to 7.89, marking an increase of 3.12.
- For PBT / Share (Rs.), as of Mar 25, the value is 1.57. This value is within the healthy range. It has increased from -1.31 (Mar 24) to 1.57, marking an increase of 2.88.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.28. This value is below the healthy minimum of 2. It has increased from -2.13 (Mar 24) to 0.28, marking an increase of 2.41.
- For PBDIT Margin (%), as of Mar 25, the value is 12.58. This value is within the healthy range. It has increased from 10.10 (Mar 24) to 12.58, marking an increase of 2.48.
- For PBIT Margin (%), as of Mar 25, the value is 10.96. This value is within the healthy range. It has increased from 8.37 (Mar 24) to 10.96, marking an increase of 2.59.
- For PBT Margin (%), as of Mar 25, the value is 2.17. This value is below the healthy minimum of 10. It has increased from -2.30 (Mar 24) to 2.17, marking an increase of 4.47.
- For Net Profit Margin (%), as of Mar 25, the value is 0.39. This value is below the healthy minimum of 5. It has increased from -3.74 (Mar 24) to 0.39, marking an increase of 4.13.
- For Return on Networth / Equity (%), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 15. It has increased from -3.61 (Mar 24) to 0.44, marking an increase of 4.05.
- For Return on Capital Employeed (%), as of Mar 25, the value is 6.99. This value is below the healthy minimum of 10. It has increased from 4.29 (Mar 24) to 6.99, marking an increase of 2.70.
- For Return On Assets (%), as of Mar 25, the value is 0.21. This value is below the healthy minimum of 5. It has increased from -1.73 (Mar 24) to 0.21, marking an increase of 1.94.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.54. This value is within the healthy range. It has decreased from 0.66 (Mar 24) to 0.54, marking a decrease of 0.12.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.68. This value is within the healthy range. It has increased from 0.66 (Mar 24) to 0.68, marking an increase of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.56. It has increased from 0.47 (Mar 24) to 0.56, marking an increase of 0.09.
- For Current Ratio (X), as of Mar 25, the value is 2.69. This value is within the healthy range. It has decreased from 3.66 (Mar 24) to 2.69, marking a decrease of 0.97.
- For Quick Ratio (X), as of Mar 25, the value is 2.52. This value exceeds the healthy maximum of 2. It has decreased from 3.39 (Mar 24) to 2.52, marking a decrease of 0.87.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.76. This value is within the healthy range. It has increased from 4.36 (Mar 24) to 4.76, marking an increase of 0.40.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 1.43. This value is below the healthy minimum of 3. It has increased from 0.94 (Mar 24) to 1.43, marking an increase of 0.49.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.04. This value is below the healthy minimum of 3. It has increased from 0.64 (Mar 24) to 1.04, marking an increase of 0.40.
- For Enterprise Value (Cr.), as of Mar 25, the value is 120.12. It has increased from 111.28 (Mar 24) to 120.12, marking an increase of 8.84.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.97. This value is below the healthy minimum of 1. It has decreased from 1.14 (Mar 24) to 0.97, marking a decrease of 0.17.
- For EV / EBITDA (X), as of Mar 25, the value is 7.72. This value is within the healthy range. It has decreased from 11.26 (Mar 24) to 7.72, marking a decrease of 3.54.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.37. This value is below the healthy minimum of 1. It has decreased from 0.46 (Mar 24) to 0.37, marking a decrease of 0.09.
- For Price / BV (X), as of Mar 25, the value is 0.42. This value is below the healthy minimum of 1. It has decreased from 0.44 (Mar 24) to 0.42, marking a decrease of 0.02.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.37. This value is below the healthy minimum of 1. It has decreased from 0.46 (Mar 24) to 0.37, marking a decrease of 0.09.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has increased from -0.08 (Mar 24) to 0.01, marking an increase of 0.09.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Ambica Agarbathies Aroma & Industries Ltd:
- Net Profit Margin: 0.39%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 6.99% (Industry Average ROCE: 29.21%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0.44% (Industry Average ROE: 23.91%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.04
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.52
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 87.7 (Industry average Stock P/E: 56.72)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.68
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0.39%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Personal Care | Shankar Towers, Power Pet, Eluru, West Godavari Dist. Andhra Pradesh 534002 | ambica.a@rediffmail.com http://ambicaagarbathi.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ambica Krishna | Chairman & Managing Director |
| Mrs. Satyavathi Perla | Whole Time Director |
| Mr. Ambica Ramachandra Rao | Whole Time Director |
| Mr. Sreedharan Venkatesan | Independent Director |
| Mr. Chunduru Anjaneya Swamy | Independent Director |
| Mr. B V Subrahmanyeswarao | Independent Director |